Rib-X Pharmaceuticals Receives $3 Million Milestone Payment from Sanofi in the RX-04 Collaboration

NEW HAVEN, Conn.--(BUSINESS WIRE)--Rib-X receives $3M milestone payment as part of worldwide research collaboration and option for license agreement with Sanofi for novel classes of antibiotics resulting from Rib-X’s RX-04 program.

Feed Date: 
February 7, 2012